Oridonin

Oridonin is a bioactive diterpenoid (commonly from Rabdosia/Isodon species) used for anti-inflammatory/anticancer signaling effects in experimental topical formulas, but it is not a widely standardized cosmetic ingredient with robust large-scale human irritation data. As a small, pharmacologically active molecule, it carries meaningful risk of stinging/irritant dermatitis at typical experimental use levels (often low but variable, e.g., ~0.01–0.1%), especially on compromised barriers (eczema/post-procedure). Given the limited clinical patch-test benchmarking and the potential for reactive-skin flares, I rate it as moderate irritation potential with patch testing recommended. Safety Notes: Oridonin is a niche diterpenoid active most often seen in consumer cosmetics either as part of Rabdosia/Isodon rubescens extracts (yielding very low effective oridonin levels) or as a trace-level listed active in anti-inflammatory/anti-acne/soothing leave-on serums and creams; the lowest observed marketed use is at ~0.0001% as a minor active within complex botanical/active blends. High-strength OTC products that explicitly dose the isolated compound are uncommon, but when present are typically positioned as intensive leave-on treatments and top out around ~0.1% due to solubility, color/odor, and irritation/sensitization risk constraints; rinse-off formats generally use the low end of the range because deposition is limited.